Skip to main content

Table 5 Group 2 Patients not achieving SVR

From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

GenderCirrhosisPrevious TreatmentBaseline PCR (log 10 IU/ml)ETRSVR12
PCR (log 10 IU/ml)
MaleNoYes5.86Not Detected5.511
FemaleNoNo5.60Not Detected4.111
MaleNoYes5.86Not Detected5.501